Latest period
$21.52M
YoY change
-35.9%
5Y CAGR
-4.8%
Peak year (2019)
$35.33M
Latest annual
$10.51M
Total Liabilities history chart for Spruce Biosciences (SPRB) from 2018 to 2025
Latest: $10.51M
Total Liabilities growth chart for Spruce Biosciences (SPRB) from 2018 to 2025
Latest: -35.9%
Total Liabilities history table for Spruce Biosciences (SPRB) from 2018 to 2025
| 2025 | $10.51M | -35.9% | −$5.88M | ||
| 2024 | $16.39M | -40.3% | −$11.05M | ||
| 2023 | $27.44M | +59.9% | +$10.28M | ||
| 2022 | $17.16M | +13.5% | +$2.05M | ||
| 2021 | $15.12M | +12.3% | +$1.66M | ||
| 2020 | $13.46M | -61.9% | −$21.87M | ||
| 2019 | $35.33M | +56.5% | +$12.75M | ||
| 2018 | $22.58M | — | — |
- 2025$10.51M-35.9%
- 2024$16.39M-40.3%
- 2023$27.44M+59.9%
- 2022$17.16M+13.5%
- 2021$15.12M+12.3%
- 2020$13.46M-61.9%
- 2019$35.33M+56.5%
- 2018$22.58M—
Total Liabilities values are taken from Spruce Biosciences's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Total Liabilities at Spruce Biosciences (SPRB)
According to Spruce Biosciences's latest reported financial statements, the company's latest reported total liabilities is $21.52M. Total liabilities sum everything the company owes at the end of each reporting period — accounts payable, accrued expenses, debt, lease obligations, and other claims — as filed on the balance sheet. Compare with total assets and total equity for solvency context.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
As of the 2025 fiscal year, Spruce Biosciences (SPRB) reported total liabilities of $10.51M – plunged 35.9% year-over-year.
Across 2020–2025 (5 years), Spruce Biosciences total liabilities produced a CAGR of -4.8% – with a net decline across the window.
Across the available history, total liabilities reached its high of $35.33M in 2019 and its low of $10.51M in 2025.
Spruce Biosciences Total Liabilities by Year
Spruce Biosciences Total Liabilities 2025: $10.51M
Spruce Biosciences posted total liabilities of $10.51M in 2025, plunged 35.9% below 2024. This figure represents the lowest annual value in the available history.
Spruce Biosciences Total Liabilities 2024: $16.39M
In 2024, Spruce Biosciences reported total liabilities of $16.39M, plunged 40.3% below 2023.
Spruce Biosciences Total Liabilities 2023: $27.44M
Spruce Biosciences total liabilities in 2023 was $27.44M, surged 59.9% from 2022.
Spruce Biosciences Total Liabilities 2022: $17.16M
2022's total liabilities for Spruce Biosciences came in at $17.16M, grew 13.5% from 2021.
Spruce Biosciences Total Liabilities 2021: $15.12M
Spruce Biosciences total liabilities in 2021 was $15.12M.
See more financial history for Spruce Biosciences (SPRB).
Sector peers by Total Liabilities
Healthcare peers of Spruce Biosciences (SPRB), ranked by their latest total liabilities
| $207.88B | |
| $137.19B | |
| $117.67B | |
| $85.94B | |
| $84.20B | |
| $81.93B | |
| $65.36B | |
| $54.86B |
- $207.88B
- $137.19B
- $117.67B
- $85.94B
- $84.20B
- $81.93B
- $65.36B
- $54.86B
Frequently asked questions
Spruce Biosciences (SPRB) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation